Skip to main content
UniHealth

Doctor search

Serena Y Tan, MD

Pathology · Stanford

NPI 1639332299

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
1
1 carrier
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

1 plan · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A109573 · Current

Licensed to practise in California · since 2009 · expires 2028-10-31 · Duke University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$17,920

Medicare paid this office $17,920 for 111 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Pathology examination of tissue using a microscope, moderately high complexity53$4,599$74
Pathology examination of specimen during surgery, first tissue block28$2,914$56
Special stained specimen slides to examine tissue including interpretation and report63$2,849$11
Special stained specimen slides to examine tissue, initial procedure40$1,542$31
Special stained specimen slides to examine tissue, each additional procedure20$1,176$25
See all 7 services
Every Original Medicare service billed
Pathology examination of tissue using a microscope, moderately high complexity53$4,599$74
Pathology examination of specimen during surgery, first tissue block28$2,914$56
Special stained specimen slides to examine tissue including interpretation and report63$2,849$11
Special stained specimen slides to examine tissue, initial procedure40$1,542$31
Special stained specimen slides to examine tissue, each additional procedure20$1,176$25
Surgical pathology consultation and report on referred slides prepared elsewhere13$964$74
Genetic sequencing localization, initial procedure17$733$39

Who their Medicare patients are

111 Original Medicare patients in 2024. Average age 67 · Under 65 21% · Women 52% · Also on Medicaid 38% · Health risk score 2.61. Sicker patients than 9 in 10 peers; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 75% · Chronic kidney disease 45% · Coronary heart disease 37% · Diabetes 36% · Cancer 32% · Depression 29% · Heart failure 24% · Atrial fibrillation 22% · COPD 16% · Dementia 14% · Stroke 12%.

The office billed $210,096, Medicare allowed $22,490 and paid $17,920; for 580 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024111580672.61$210,096$17,920
202354268643.66$78,296$8,185
202225150673.87$35,117$4,438
202132174613.44$31,417$4,967
202023140572.53$26,815$4,734

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Pathology examination of tissue using a microscope, moderately high complexity27$2,184$75
Special stained specimen slides to examine tissue including interpretation and report30$1,298$11
Special stained specimen slides to examine tissue, initial procedure23$942$32
Pathology examination of specimen during surgery, first tissue block12$875$58
Special stained specimen slides to examine tissue, each additional procedure13$580$26

2022: 3 services

Original Medicare services billed in 2022
Pathology examination of tissue using a microscope, moderately high complexity13$1,086$78
Special stained specimen slides to examine tissue including interpretation and report16$709$11
Special stained specimen slides to examine tissue, initial procedure14$682$32

2021: 3 services

Original Medicare services billed in 2021
Pathology examination of tissue using a microscope, moderately high complexity24$1,843$74
Special stained specimen slides to examine tissue including interpretation and report26$906$11
Special stained specimen slides to examine tissue, initial procedure16$596$33

2020: 3 services

Original Medicare services billed in 2020
Pathology examination of tissue using a microscope, moderately high complexity13$1,458$81
Special stained specimen slides to examine tissue, initial procedure12$582$34
Special stained specimen slides to examine tissue including interpretation and report14$556$12

Medicaid work

$27,584 in 2024

Medicaid paid $27,584 for 505 billed services this clinician did in 2024, up to 27 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
TISSUE EXAM BY PATHOLOGIST166$14,197
Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry245$8,759
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure94$4,627
Medicaid work by year
2024505327$27,584
2023753532$65,099
2022401433$38,935
2021518431$41,733
2020433427$35,396
201937120$4,580
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST370$44,156
TISSUE EXAM BY PATHOLOGIST95$10,162
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure161$6,748
TISSUE EXAM BY PATHOLOGIST114$3,278
IMHCHEM/IMCYTCHM EA ADD ANTB13$756

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST237$29,647
TISSUE EXAM BY PATHOLOGIST56$4,646
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure58$3,229
TISSUE EXAM BY PATHOLOGIST50$1,412

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST249$29,200
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure125$6,242
TISSUE EXAM BY PATHOLOGIST80$4,601
TISSUE EXAM BY PATHOLOGIST64$1,690

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST212$24,306
TISSUE EXAM BY PATHOLOGIST84$5,681
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure75$3,605
TISSUE EXAM BY PATHOLOGIST62$1,805

2019

Largest Medicaid services in 2019
TISSUE EXAM BY PATHOLOGIST37$4,580

Money from drug and device companies

$28 in 2025

A payment is not proof that care is biased.

Payments by company
Novartis PharmaceuticalsVijoice$28
1 payment
  • Meals for Vijoice · 2025-02-05 · $28
See the published payment
Every published payment
Novartis PharmaceuticalsMeals · 2025-02-05Vijoice$28

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1639332299
Licence
CA A109537, CA A109573California A109573: Current · expires 2028-10-31
Trained
Duke University School of Medicine, 2008
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0213X (207ZP0213X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2008-07-03
NPI last updated
2024-03-13
NPI record certified
2024-03-13

This is when the NPI record was last certified, not a medical board exam.